May 11, 2022

Side effects, dosage, cost, alternatives, etc.

The Food and Drug Administration (FDA) approves prescription drugs such as Avsola to treat certain conditions.

Avsola for Crohn’s disease

Avsola is approved to treat Crohn’s disease which is moderate to severe in adults and children 6 years of age and older. Avsola is prescribed when you are currently having symptoms of Crohn’s disease, but some other medicines have not helped.

Crohn’s disease is a type of inflammatory bowel disease that causes inflammation of the digestive tract. This can cause symptoms that can include bloody stools, diarrhea, cramps, and abdominal pain.

In severe cases, Crohn’s disease can also cause fistulas. These are passages between two parts of the body that are usually not connected. For adults with Crohn’s disease, Avsola is given to help heal fistulas that have formed between the intestines and the skin, or between the rectum and the vagina. Avsola is also given to help maintain healing of a fistula that has already been treated.

Effectiveness for Crohn’s disease

Clinical studies have shown Avsola to be effective in treating Crohn’s disease. Avsola’s active drug infliximab recommended as a treatment option by the American College of Gastroenterology guidelines for Crohn’s disease.

For more information on the performance of the drug in clinical studies, see Avsola prescribing information.

Avsola for ulcerative colitis

Avsola is approved to treat ulcerative colitis in adults and children 6 years of age and older. Avsola is prescribed to treat moderate to severe ulcerative colitis when certain other medicines have not helped.

In some cases, adults may take medicines called corticosteroids for ulcerative colitis. With Avsola treatment, you may no longer need to take corticosteroids.

Ulcerative colitis is a disease that causes inflammation of the colon (large intestine) and rectum. This can lead to symptoms like diarrhea, abdominal pain, fever, and unintentional weight loss.

Efficacy for ulcerative colitis

Avsola has been shown to be effective in the treatment of Crohn’s disease in clinical studies. Avsola’s active drug infliximab recommended as a treatment option by the American College of Gastroenterology guidelines for ulcerative colitis.

For more information on the performance of the drug in clinical studies, see Avsola prescribing information.

Avsola for rheumatoid arthritis

Avsola is approved for the treatment of adults with moderate to severe rheumatoid arthritis, in combination with methotrexate (Trexall).

Rheumatoid arthritis is a disease that causes inflammation and pain in your joints. In some cases, it can also affect other parts of your body such as your mouth, lungs or eyes.

Effectiveness for rheumatoid arthritis

Avsola has been shown to be effective in the treatment of rheumatoid arthritis. Infliximab, the active drug in Avsola, recommended as a treatment option by the American College of Rheumatology 2015 guidelines for rheumatoid arthritis.

For more information on the performance of the drug in clinical studies, see Avsola prescribing information.

Avsola for psoriatic arthritis

Avsola is prescribed to treat active psoriatic arthritis in adults. “Active” means you are currently showing symptoms.

Psoriatic arthritis is a type of arthritis in which you also have a condition called psoriasis. Symptoms can include swelling in the joints and fatigue.

Effectiveness for Psoriatic Arthritis

Avsola has been shown to be effective in the treatment of psoriatic arthritis. Avsola’s active drug infliximab recommended as a treatment option by the American College of Rheumatology and the National Psoriasis Foundation guidelines for psoriatic arthritis.

For more information on the performance of the drug in clinical studies, see Avsola prescribing information. You can also visit our arthritis center.

Avsola for plaque psoriasis

Avsola is approved to treat chronic (long lasting) and severe plaque psoriasis in adults. Avsola is prescribed for adults who:

  • may take systemic medicines (medicines that work throughout the body) for plaque psoriasis
  • have certain conditions or factors that prevent them from using systemic treatments other than Avsola

Plaque psoriasis causes itchy patches (scaly patches) to form on your skin. They can appear red or pink in lighter skin tones and dark brown or purple in darker skin tones. Plaque psoriasis is considered serious if it covers a large area of ​​your body or causes a handicap in your daily life.

Effectiveness for plaque psoriasis

Avsola has been shown to be effective in the treatment of plaque psoriasis. Infliximab, the active drug in Avsola, recommended as a treatment option by the American Academy of Dermatology guidelines for plaque psoriasis.

For more information on the performance of the drug in clinical studies, see Avsola prescribing information. You can also visit our dedicated psoriasis center.

Avsola for ankylosing spondylitis

Avsola is prescribed to treat active ankylosing spondylitis in adults. “Active” means you are currently showing symptoms. Ankylosing spondylitis is a type of arthritis that affects your spine. Symptoms may include pain or stiffness in the spine and lower back.

Effectiveness for ankylosing spondylitis

Avsola has been shown to be effective in the treatment of Crohn’s disease. Infliximab, the active drug in Avsola, is recommended as a treatment option by the American College of Rheumatology, the Spondylitis Association of America, and the Spondyloarthritis Research and Treatment Network 2015 guidelines for ankylosing spondylitis.

For more information on the performance of the drug in clinical studies, see Avsola prescribing information.

Avsola and the children

Avsola is approved to treat Crohn’s disease and ulcerative colitis in children 6 years of age and older. For more information, see the “Avsola for Crohn’s disease” and “Avsola for ulcerative colitis” sections above.


Source link